| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.089 | 0.1 |